Home » Stocks » CLXT

Calyxt, Inc. (CLXT)

Stock Price: $3.78 USD 0.00 (0.00%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 136.15M
Revenue (ttm) 25.88M
Net Income (ttm) -43.80M
Shares Out 37.20M
EPS (ttm) -1.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $3.78
Previous Close $3.78
Change ($) 0.00
Change (%) 0.00%
Day's Open 3.78
Day's Range 3.70 - 3.81
Day's Volume 82,933
52-Week Range 3.16 - 12.43

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 hour ago - Zacks Investment Research

ROSEVILLE, Minn., July 27, 2021 /PRNewswire/ -- Calyxt, Inc.  (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced that, in accordance with the offer letter entered into on July...

2 days ago - PRNewsWire

ROSEVILLE, Minn., July 19, 2021 /PRNewswire/ --  Calyxt, Inc.  (NASDAQ: CLXT) will hold a conference call on Thursday, August 5, 2021 at 4:30 p.m.

1 week ago - PRNewsWire

Biotechnology company Calyxt Inc (NASDAQ: CLXT) has appointed Michael A. Carr as President and Chief Executive Officer, effective July 27, 2021.

1 week ago - Benzinga

ROSEVILLE, Minn., July 15, 2021 /PRNewswire/ -- Calyxt, Inc.  (NASDAQ: CLXT), a plant-based biotechnology platform company, today announced the appointment of Michael A.

2 weeks ago - PRNewsWire

Triploid Breeding Process is Calyxt's Second Announced Advancement and Part of a Comprehensive Approach to Improving Hemp Genetics ROSEVILLE, MN / ACCESSWIRE / July 8, 2021 / Calyxt, Inc. (NASDAQ:CLXT),...

3 weeks ago - Accesswire

Doudna's breakthrough in CRISPR has since ushered in a new era of genetic engineering, making these the best gene-editing stocks to buy. The post The Top 7 Gene-Editing Stocks to Buy for the Biggest Sci...

Other stocks mentioned: BEAM, CLLS, CRSP, EDIT, NTLA, SGMO
4 weeks ago - InvestorPlace

Early-Stage Validation that Next Generation Premium Soybean Product Performance is Best-in-Class for High Oleic, Ultra-Low Linolenic Profile Successful Transformation of Hemp Genome Enables Step Change ...

2 months ago - Accesswire

Next Generation Premium Soybean Product Line Contains Ultra-Low Levels of Linolenic Acid Positioning it to be the Most Stable Premium Soybean Oil Available on the Market R&D Advancement with Complex Pla...

2 months ago - Accesswire

Calyxt (CLXT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

New Hemp Transformation Technology Unlocks Capabilities to Selectively Breed and Deliver Improvements in Hemp Traits for Key Markets Including Protein, Fiber, Advanced Materials and Wellness Patent-Pend...

3 months ago - Accesswire

Here's what to look for and what to steer clear of.

Other stocks mentioned: TMO, ZY
3 months ago - The Motley Fool

ROSEVILLE, MN / ACCESSWIRE / April 20, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor and industry conferences during the month of May 2...

3 months ago - Accesswire

Calyxt to Host First Quarter 2021 Financial Results Conference Call on Thursday, Ma y 6 , 202 1 at 4 :30 p .m. Eastern Time ROSEVILLE, MN / ACCESSWIRE / April 15, 2021 / Calyxt, Inc. (NASDAQ:CLXT), a pl...

3 months ago - Accesswire

Calyxt (CLXT) delivered earnings and revenue surprises of -32.00% and 77.18%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

-Shares of Calyxt (NASDAQ:CLXT) were flat after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 10.81% year over year to ($0.33), which missed the es...

4 months ago - Benzinga

Continued to Progress Development of Winter Oats and Hemp, Both Targeted at Large Addressable Markets Secured Commitment from ADM to Purchase Remaining 2019 Grain Inventory and All 2020 Grain Production...

4 months ago - Accesswire

Calyxt (CLXT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

4 months ago - Zacks Investment Research

ROSEVILLE, MN / ACCESSWIRE / March 3, 2021 / Calyxt, Inc . (NASDAQ:CLXT), a plant-based technology company, will participate in the following investor conferences during the month of March 2021: Bank of...

4 months ago - Accesswire

World-Renowned Plant-Biochemistry Experts Named to Calyxt's Scientific Advisory Board Chaired by Company Co-Founder Dan Voytas, Ph.D. New Strategic Initiative to Identify High Value Plant-Derived Produc...

4 months ago - Accesswire

Calyxt sells a premium soybean cooking oil Calyno   TALEN gene-editing technology is a game-changer   Strong management team with proven track record   What Calyxt does:  Calyxt Inc (NASDAQ:CLXT) is a p...

5 months ago - Proactive Investors

Calyxt Inc (NASDAQ:CLXT) shares jumped Tuesday after an analyst at Canaccord Genuity Capital markets doubled the firm's price target for the company from $8 to $16 and reiterated a "Buy" rating in a not...

5 months ago - Proactive Investors

Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.

5 months ago - Zacks Investment Research

Calyxt (CLXT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

5 months ago - Zacks Investment Research

These 5 stocks have good reason for further upside.

Other stocks mentioned: BB, CAR, DDD, DQ
6 months ago - Zacks Investment Research

Does Calyxt (CLXT) have what it takes to be a top stock pick for momentum investors? Let's find out.

6 months ago - Zacks Investment Research

Between these seven genetic editing pioneers, you have the widest exposure to the biggest scientific breakthrough of the century. The post 7 CRISPR Stocks for the Future of Medicine appeared first on In...

Other stocks mentioned: BEAM, CLLS, CRSP, EDIT, NTLA, SGMO
6 months ago - InvestorPlace

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has contracted to sell all 2020 grain production of its high oleic soybean to AD...

Other stocks mentioned: ADM
7 months ago - Business Wire

Project delays and slower than anticipated growth contradicts CLXT's business model that claim a speedy development cycle using novel gene-editing technologies.

7 months ago - Seeking Alpha

Calyxt (CLXT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

8 months ago - Zacks Investment Research

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, today announced a research collaboration with NRGene® that includes the adoption of NRGene's cloud-based...

8 months ago - Business Wire

Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, has reported its financial results for the third quarter ended September 30, 2020. Execution of commerci...

8 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has agreed to commercial terms with S&W Seed Company (Nasdaq: SANW), a global ag...

Other stocks mentioned: SANW
9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will host a Virtual Analyst Day on Tuesday, November 17, 2020 at 4:00 p.m. Eastern time. The Virtual Ana...

9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced the closing of its previously announced registered direct offering of 3,...

9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT) (the “Company”), a plant-based technology company, today announced that it has entered into definitive agreements with institutional invest...

9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced today that it has appointed Sarah Reiter as Vice President, Business Development. In this role...

9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, will hold a conference call on Thursday, November 5, 2020 at 4:30 p.m. Eastern time to discuss its resul...

9 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

11 months ago - Business Wire

Calyxt, Inc. (CLXT) CEO James Blome on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

11 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc.

11 months ago - Business Wire

ROSEVILLE, Minn.--(BUSINESS WIRE)--Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company, announced the appointment of current board member Yves Ribeill, Ph.D., as Chairman. This appointment coi...

1 year ago - Business Wire

U.S. consumer confidence gained in May and beat the expectations of economists polled by Dow Jones.

Other stocks mentioned: BGS, INO, MED, PRPL
1 year ago - Zacks Investment Research

Calyxt (CLXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

1 year ago - Zacks Investment Research

Calyxt's (CLXT) CEO Jim Blome on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Calyxt, Inc.'s (CLXT) CEO Jim Blome on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Investors shouldn't forget that the world of biotech extends beyond biopharmaceuticals.

Other stocks mentioned: DTIL, CLLS
1 year ago - The Motley Fool

About CLXT

Calyxt, Inc., a technology company, focuses on delivering plant-based solutions in the United States. It engages in the development of improved digestibility alfalfa; high fiber wheat; high oleic low linolenic soybeans; winter oats; hemp; fat soybeans; and cold storable potatoes. As of March 4, 2021, the company had nine projects at Phase I stage or later in development across alfalfa, hemp, oats, soybeans, and wheat. Calyxt, Inc. has a research collaboration with NRGene, which includes the adoption of NRGene's cloud-based genomics platform to ... [Read more...]

Industry
Packaged Foods
IPO Date
Jul 20, 2017
Stock Exchange
NASDAQ
Ticker Symbol
CLXT
Full Company Profile

Financial Performance

In 2020, Calyxt's revenue was $23.85 million, an increase of 226.91% compared to the previous year's $7.30 million. Losses were -$44.84 million, 13.2% more than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Calyxt stock is "Buy." The 12-month stock price forecast is 7.17, which is an increase of 89.68% from the latest price.

Price Target
$7.17
(89.68% upside)
Analyst Consensus: Buy